Huntington National Bank »

Leap Therapeutics shares owned by Huntington National Bank

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Huntington National Bank from 13F filings

Historical chart of Huntington National Bank investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Huntington National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Huntington National Bank

Quarter filed Position value Share count Share price at filing
2025-09-30 $454 1.0k 0.45
2025-06-30 $297 1.0k 0.30
2025-03-31 $305 1.0k 0.31

More positions owned by Huntington National Bank

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Jp Morgan Chase & Co Common Stock (JPM)
Apple Common Stock (AAPL)
Alphabet Common Stock (GOOGL)
Vanguard Exchange Traded (Principal) (VEA)
Ishares Exchange Traded (Principal) (IVV)
Broadcom Common Stock (AVGO)
Amazon.com Common Stock (AMZN)
Ishares Exchange Traded (Principal) (IJH)
Meta Platforms Common Stock (META)
Netflix Common Stock (NFLX)
Ishares Exchange Traded (Principal) (IJR)
Exxon Mobil Corp Common Stock (XOM)
Eli Lilly & Co Common Stock (LLY)

View all positions for Huntington National Bank

Top funds holding Leap Therapeutics

Gilead Sciences
Acadian Asset Management
Vanguard Group
HighTower Advisors
Simplify Asset Management
Geode Capital Management
Jane Street
Key Client Fiduciary Advisors
State Street Corporation
BlackRock
Hrt Financial
Two Sigma Advisers
Susquehanna International
Citadel Advisors
Two Sigma Investments

View all funds holding Leap Therapeutics